Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis

被引:314
作者
Piatek, AS
Tyagi, S
Pol, AC
Telenti, A
Miller, LP
Kramer, FR
Alland, D [1 ]
机构
[1] Montefiore Med Ctr, Dept Med, Div Infect Dis, Bronx, NY 10467 USA
[2] Publ Hlth Res Inst City New York Inc, Dept Mol Genet, New York, NY 10016 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[4] CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland
[5] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA
关键词
pathogen screening; molecular probes; genetic testing; rifampin;
D O I
10.1038/nbt0498-359
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We developed a new approach to DNA sequence analysis that uses fluorogenic reporter molecules-molecular beacons--and demonstrated their ability to discriminate alleles in real-time PCR assays of genomic DNA. A set of overlapping molecular beacons was used to analyze an 81-bp region of the Mycobacterium tuberculosis rpoB gene for mutations that confer resistance to the antibiotic rifampin. In a blinded study of 52 rifampin-resistant and 23 rifampin-susceptible clinical isolates, this method correctly detected mutations in all of the resistant strains and in none of the susceptible strains. The assay was carried out entirely in sealed PCR tubes and was simple to perform and interpret. This approach can be used to analyze any DNA sequence of moderate length with single base pair accuracy.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 28 条
[1]   TRANSMISSION OF TUBERCULOSIS IN NEW-YORK-CITY - AN ANALYSIS BY DNA-FINGERPRINTING AND CONVENTIONAL EPIDEMIOLOGIC METHODS [J].
ALLAND, D ;
KALKUT, GE ;
MOSS, AR ;
MCADAM, RA ;
HAHN, JA ;
BOSWORTH, W ;
DRUCKER, E ;
BLOOM, BR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (24) :1710-1716
[2]   GAUCHER DISEASE - NEW MOLECULAR APPROACHES TO DIAGNOSIS AND TREATMENT [J].
BEUTLER, E .
SCIENCE, 1992, 256 (5058) :794-799
[3]  
*CDC, 1993, MMWR-MORBID MORTAL W, V42, P961
[4]   Surveillance of drug resistance for tuberculosis control: Why and how? [J].
Chaulet, P ;
Boulahbal, F ;
Grosset, J .
TUBERCLE AND LUNG DISEASE, 1995, 76 (06) :487-492
[5]   RAPID DETECTION OF RIFAMPICIN RESISTANCE IN SPUTUM AND BIOPSY SPECIMENS FROM TUBERCULOSIS PATIENTS BY PCR AND LINE PROBE ASSAY [J].
DEBEENHOUWER, H ;
LHIANG, Z ;
JANNES, G ;
MIJS, W ;
MACHTELINCKX, L ;
ROSSAU, R ;
TRAORE, H ;
PORTAELS, F .
TUBERCLE AND LUNG DISEASE, 1995, 76 (05) :425-430
[6]   AN OUTBREAK OF TUBERCULOSIS CAUSED BY MULTIPLE-DRUG-RESISTANT TUBERCLE-BACILLI AMONG PATIENTS WITH HIV-INFECTION [J].
FISCHL, MA ;
UTTAMCHANDANI, RB ;
DAIKOS, GL ;
POBLETE, RB ;
MORENO, JN ;
REYES, RR ;
BOOTA, AM ;
THOMPSON, LM ;
CLEARY, TJ ;
LAI, SH .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :177-183
[7]   TREATMENT OF 171 PATIENTS WITH PULMONARY TUBERCULOSIS RESISTANT TO ISONIAZID AND RIFAMPIN [J].
GOBLE, M ;
ISEMAN, MD ;
MADSEN, LA ;
WAITE, D ;
ACKERSON, L ;
HORSBURGH, CR .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :527-532
[8]  
Heifets L B, 1986, Semin Respir Infect, V1, P242
[9]  
Kent P. T., 1985, PUBLIC HLTH MYCOBACT
[10]   PCR ASSAY BASED ON DNA CODING FOR 16S RIBOSOMAL-RNA FOR DETECTION AND IDENTIFICATION OF MYCOBACTERIA IN CLINICAL-SAMPLES [J].
KOX, LFF ;
VANLEEUWEN, J ;
KNIJPER, S ;
JANSEN, HM ;
KOLK, AHJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (12) :3225-3233